Featured Posts
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
National Review
Telehealth Is Less Promising Than It First Seemed
A key issue facing Congress in its postelection, “lame duck” session is whether to extend regulatory flexibilities expiring at year end that make telehealth services more…
Search Posts
The Economic Standard
Drug Reference Pricing Threatens Patient Health, Innovation
The Economic Standard cites Research Fellow Patrick Hedger and CEI’s event on drug reference pricing: Some recent proposals to lower drug prices are…
News Release
Foreign Reference Pricing Schemes Threaten Patient Health and America’s Leadership in Medical Innovation
International policy experts and patients gathered today in Washington, D.C. to discuss the potential impact of foreign reference pricing schemes, which have been proposed by the…
News Release
International Experts Voice Concerns About International Pricing Index and Foreign Reference Pricing Proposals for Prescription Drugs
To address the cost of prescription medicines, the Trump administration and congressional leaders have proposed instituting international reference pricing policies, like the International Pricing Index…
Letters
CEI Joins Coalition Letter Opposing Pelosi Drug Tax Plan
Dear Members of Congress: We write in opposition to the prescription drug pricing bill offered by House Speaker Nancy Pelosi that would impose an excise…
Blog
Bogus E-cigarette Panic Literally Killing People
Is this a story from The Onion? It’s a question we often ask ourselves these days when we encounter stories online that seem too ridiculous…
Letters
CEI Joins Coalition Letter to Urge President Trump to Halt Regulatory Assault on Innovative Electronic Cigarette Industry
We urge you to immediately halt the Food and Drug Administration’s aggressive regulatory assault on businesses who sell and consumers who rely on less harmful…